SolanaSOL, coin
DevelopingETF

Injective guide compares direct INJ ownership with Canary Staked INJ ETF shares

Injective published a guide on Oct. 14, 2026 comparing direct INJ ownership with shares of the Canary Staked INJ ETF, which trades on Nasdaq as INJC.

Why it matters

The account is a company-authored explanation of how a staked ETF differs from holding the token itself, and no second outlet has reported it. The one gap is the sponsor fee rate, which the supplied material does not give, so the cost side of the comparison stays open. Its significance for the ETF itself is limited until the fee schedule or independent reporting appears.

Key facts

Injective published a guide on Oct. 14, 2026 comparing direct INJ ownership with shares of the Canary Staked INJ ETF.

Reported by Blockchain.News

The guide says INJ is the network's native asset, used to pay fees, stake to secure the chain and vote on upgrades.

Reported by Blockchain.News

Direct INJ holders control their own keys, can choose a validator and can use INJ across Injective apps.

Reported by Blockchain.News

The guide says INJC investors hold fund shares in a brokerage account, do not vote, cannot move tokens onchain and cannot redeem shares for INJ.

Reported by Blockchain.News

BitGo is the custodian of the fund, which stakes part of its INJ and keeps some unstaked to meet redemptions.

Reported by Blockchain.News

INJ trades 24/7 on crypto venues, while INJC trades on Nasdaq during market hours.

Reported by Blockchain.News

The guide says direct INJ holders may face exchange fees, network withdrawal fees and validator commission when staking.

Reported by Blockchain.News

The guide does not provide a fee rate for the ETF; INJC investors face a sponsor fee charged as an annual percentage of assets, staking-related fees taken from rewards and brokerage commission or bid-ask spread.

Reported by Blockchain.News

What happened

Injective published a guide on Oct. 14, 2026 that sets direct ownership of the INJ token against shares of the Canary Staked INJ ETF, which trades on Nasdaq as INJC, and Blockchain.News reported the comparison from that material. The guide says INJ is the network's native asset, used to pay fees, stake to secure the chain and vote on upgrades, and that direct holders keep their own keys, choose a validator and use INJ across Injective apps. It says INJC investors hold fund shares in a brokerage account with staking built into the product, do not vote, cannot move tokens onchain and cannot redeem shares for INJ. The guide names BitGo as the fund's custodian and says the fund stakes part of its INJ while keeping some unstaked to meet redemptions. On cost, it sets exchange fees, network withdrawal fees and validator commission against a sponsor fee charged as an annual percentage of assets, staking fees taken from rewards and brokerage commission or bid-ask spread, but it gives no fee rate for the ETF. Only Blockchain.News has covered this, and the claims are Injective's own, so the comparison has not been reported independently.

How the story developed

  1. Official statement

    Injective publishes its INJ versus INJC comparison guide

    The company-side-by-side comparison of direct token ownership and staked ETF shares, naming BitGo as custodian and Nasdaq as the INJC trading venue.

    Blockchain.News

  2. First report

    First report by Blockchain.News

    INJ vs. INJC: Injective (INJ)compares direct token holding with ETF shares

    Blockchain.News

  3. Update

    Blockchain.News reports the Injective guide

    The only outlet in the evidence set to cover the comparison, reproducing the guide's claims on custody, staking, voting rights and fees.

    Blockchain.News

Affected entities

Original sources

PublisherReportRolePublished
Blockchain.News
Crypto media
INJ vs. INJC: Injective (INJ)compares direct token holding with ETF sharesOriginal